Ito, Willian
Choi, Nicholas
Letner, George
Genz, Nicholas
Prokop, Dillon
Valadon, Crystal
Sardiu, Mihaela E.
Smith, Holly
Whiles, Bristol B.
Molina, Wilson R. http://orcid.org/0000-0003-1379-237X
Article History
Received: 21 April 2023
Accepted: 16 January 2024
First Online: 15 March 2024
Declarations
:
: Wilson R. Molina is a consultant for Olympus, Boston Scientific, Johnson & Johnson, IPG, and Fortec. All other authors have no additional disclosures.
: This retrospective study was approved by the University of Kansas Medical Center’s Institutional Review Board (IRB Protocol Number: STUDY00144857, title: “<i>The Impact of Endourological Diseases and Management: Experience at University of Kansas Medical Center</i>”) and performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: As a retrospective case–control study, a waiver for HIPAA authorization, thereby <i>consent to participate</i>, was requested and granted by the local Institutional Review Board (protocol number STUDY00144857, title: “<i>The Impact of Endourological Diseases and Management: Experience at University of Kansas Medical Center</i>”).